"Testing and Treatment for Latent TB Infection: Now is the Time!"

Medicine Grand Round C. Robert Horsburgh, Jr, MD, MUS Professor of Epidemiology Biostatistics Global Health and Medicine Schools of Public Health and Medicine Boston University

March 24, 2017
8 am - 9 am
Location
DHMC- Auditorium E
Sponsored by
Geisel School of Medicine
Audience
Public
More information
Jessica Kinzie
603-650-6722

Medicine Grand Rounds Friday, March 24, 2017

“Testing and Treatment for Latent TB Infection: Now is the Time!”

C. Robert Horsburgh, Jr, MD, MUS

8:00 a.m. – 9:00 a.m.

Dr. Horsburgh’s career has been dedicated to understanding and preventing mycobacterial diseases, particularly drug-resistant tuberculosis and tuberculosis in HIV-infected persons.  He received medical training at the Massachusetts General Hospital and the University of Colorado Hospitals. He received specialty training in tuberculosis at National Jewish Hospital in Denver, a renowned referral center for drug-resistant TB. He then moved to CDC, where he held was Director of the Surveillance and Epidemiologic Investigations Branch of the Division of Tuberculosis Elimination. Subsequently, he directed the Mycobacterial Clinical Center at Grady Memorial Hospital in Atlanta before moving to Boston University School of Public Health in 2000. Dr. Horsburgh is an experienced TB clinician, having cared for TB patients at National Jewish Hospital, the Atlanta/Fulton County Health Department’s TB clinic and the Boston Public Health Commission’s TB clinic. His research has focused on TB clinical and epidemiologic research and clinical trials. He has published 180 peer-reviewed articles and has given numerous invited lectures at national and international TB meetings on various aspects of tuberculosis. He served as Chairman of the infectious Diseases Society of America’s TB Committee, Chairman of the Steering Committee of the U.S. Tuberculosis Trials Consortium (TBTC), Chairman of the Steering Committee of the U.S. Tuberculosis Epidemiologic Studies Consortium and Co-Chair of the “Access and Appropriate Use Work Group” of the Gates Foundation’s Critical Path to TB Drug Regimens Initiative. He is a member of the U.S. Advisory Committee for the Elimination of Tuberculosis (ACET), which advises CDC on tuberculosis control and elimination strategy, and he is the President-Elect of the North American Region of the International Union Against Tuberculosis and Lung Disease (IUATLD). In addition, he is Co-Chairman of the Drug-Resistance Working Group of the IUATLD, Chair of the MDR/XDR-TB Working Group of the TBTC, and Chairman of the Steering Committee of Research Excellence to Stop TB Resistance (RESIST-TB), an international organization that advocates for clinical trials of Drug-resistant TB (http://www.resisttb.org/).

If you are unable to attend and would like to either view Grand Rounds live on your computer or if you would like to view it another time, please use this link. http://med.dartmouth-hitchcock.org/education/dept_medicine_grand_rounds_live.html

** The Dartmouth-Hitchcock Medical Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education programs for physicians.**

** The Dartmouth-Hitchcock Medical Center designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. **

Location
DHMC- Auditorium E
Sponsored by
Geisel School of Medicine
Audience
Public
More information
Jessica Kinzie
603-650-6722